Videos

Michael Hill talks with Diabetes in Control Publisher Steve Freed during a Skype interview. In part 8 of this Exclusive Interview, the launch of the Guardian System platform and the Guardian Connect, a standalone system.

In part 7 of this Exclusive Interview, Michael Hill explains the education required to use the system.

In part 6 of this Exclusive Interview, understanding how a parent or caregiver can monitor an adolescent who is using the system.

Michael Hill explains how the system works when a patient's blood glucose drops.

In part 4 of this Exclusive Interview, Michael Hill explains the safety of the MiniMed 670G System and the results of the clinical trial, which included testing incidences of DKA and severe hypoglycemia requiring assistance.

In part 3 of this Exclusive Interview, Michael Hill explains the accuracy, fixed rate and insulin delivery delay of the Minimed 670G System.

In part 2 of this Exclusive Interview, Michael Hill explains what the hybrid closed-loop system can and can't do as well as some of the benefits.

In part 1 of this Exclusive Interview, Michael Hill discusses the release of the hybrid closed-loop system, the Minimed 670G.

Blandine Lacroix talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 5, the conclusion of this Exclusive Interview, Blandine Lacroix charges the medical community with understanding obesity and being of support to those with the disease.

Blandine Lacroix talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 4 of this Exclusive Interview, Blandine Lacroix explains the motivational interview process.